Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30449625

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2019 Jan 5
First author
Gillison ML

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2019 Jan 5;393(10166):5-7. doi: 10.1016/S0140-6736(18)32930-1.
    note
    Source null
    related pmid
    30449624
    relationship
    Comment in
  2. citation
    Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):705-709. doi: 10.1016/j.ijrobp.2019.02.054.
    note
    Source null
    related pmid
    31204653
    relationship
    Comment in
  3. citation
    Bull Cancer. 2020 Mar;107(3):293-294. doi: 10.1016/j.bulcan.2020.02.002.
    note
    Source null
    related pmid
    32113612
    relationship
    Comment in
  4. citation
    Lancet. 2020 Mar 7;395(10226):784. doi: 10.1016/S0140-6736(20)30454-2.
    note
    Source null
    related pmid
    32145794
    relationship
    Erratum in

Authors and identifiers

  1. name
    Gillison ML
    type
    Author
  2. name
    Trotti AM
    type
    Author
  3. name
    Harris J
    type
    Author
  4. name
    Eisbruch A
    type
    Author
  5. name
    Harari PM
    type
    Author
  6. name
    Adelstein DJ
    type
    Author
  7. name
    Jordan RCK
    type
    Author
  8. name
    Zhao W
    type
    Author
  9. name
    Sturgis EM
    type
    Author
  10. name
    Burtness B
    type
    Author
  11. name
    Ridge JA
    type
    Author
  12. name
    Ringash J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Gillison ML
    type
    Author
  2. name
    Trotti AM
    type
    Author
  3. name
    Harris J
    type
    Author
  4. name
    Eisbruch A
    type
    Author
  5. name
    Harari PM
    type
    Author
  6. name
    Adelstein DJ
    type
    Author
  7. name
    Jordan RCK
    type
    Author
  8. name
    Zhao W
    type
    Author
  9. name
    Sturgis EM
    type
    Author
  10. name
    Burtness B
    type
    Author
  11. name
    Ridge JA
    type
    Author
  12. name
    Ringash J
    type
    Author
bibliography ids
  1. nci-bib-7cbe8ca7372fb6a85042c91b
book metadata
content sha256
732ffba8f1befe5cf4f3a6b4941aaeffef508182b0b418799ae6fa72a1a26a57
document type
citation
dois
  1. 10.1016/S0140-6736(18)32779-X
electronic publication date
display
2018 Nov 15
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:30449625
immutable id
pubmed:30449625@732ffba8f1befe5cf4f3a6b4941aaeffef508182b0b418799ae6fa72a1a26a57
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10166
name
Lancet (London, England)
nlm unique id
2985213R
pages
40-50
volume
393
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2019 Jan 5;393(10166):5-7. doi: 10.1016/S0140-6736(18)32930-1.
    note
    Source null
    related pmid
    30449624
    relationship
    Comment in
  2. citation
    Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):705-709. doi: 10.1016/j.ijrobp.2019.02.054.
    note
    Source null
    related pmid
    31204653
    relationship
    Comment in
  3. citation
    Bull Cancer. 2020 Mar;107(3):293-294. doi: 10.1016/j.bulcan.2020.02.002.
    note
    Source null
    related pmid
    32113612
    relationship
    Comment in
  4. citation
    Lancet. 2020 Mar 7;395(10226):784. doi: 10.1016/S0140-6736(20)30454-2.
    note
    Source null
    related pmid
    32145794
    relationship
    Erratum in
outcomes validated
false
pmid
30449625
provenance
batch id
438b2803888025c6cf56
provider
NCBI PubMed ESummary
record sha256
d7306d1fa7dfcb5e31c250bd8ad94cfd74e18500d620f2f4fa042377cd786974
response sha256
0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
retrieved at
2026-09-09T23:47:36.359220+00:00
publication date
display
2019 Jan 5
precision
day
year
2019
publication types
  1. Comparative Study
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
  7. Equivalence Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30449625/
title
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.

Preserved source evidence · Not medical advice